Cybin to participate in the canaccord genuity 44th annual growth conference

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, will participate in a fireside chat at the canaccord genuity 44th annual growth conference, taking place august 13-14, 2024 in boston, ma. mr. drysdale's.
CYBN Ratings Summary
CYBN Quant Ranking